Interpace Biosciences Inc (IDXG)
1.45
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Interpace Biosciences Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 5.999M |
| March 31, 2023 | 6.16M |
| December 31, 2022 | 6.206M |
| September 30, 2022 | 7.143M |
| June 30, 2022 | -0.392M |
| March 31, 2022 | -0.373M |
| December 31, 2021 | -0.315M |
| September 30, 2021 | -0.453M |
| June 30, 2021 | -0.671M |
| March 31, 2021 | -1.536M |
| December 31, 2020 | -1.575M |
| September 30, 2020 | -1.301M |
| June 30, 2020 | -14.82M |
| March 31, 2020 | -13.95M |
| December 31, 2019 | -13.95M |
| September 30, 2019 | -13.98M |
| June 30, 2019 | -0.405M |
| March 31, 2019 | -0.388M |
| December 31, 2018 | -0.449M |
| September 30, 2018 | -0.388M |
| June 30, 2018 | -0.108M |
| March 31, 2018 | -0.089M |
| December 31, 2017 | -0.029M |
| September 30, 2017 | -0.029M |
| June 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 26.98M |
| June 30, 2016 | 26.94M |
| March 31, 2016 | 26.86M |
| December 31, 2015 | 26.40M |
| September 30, 2015 | -15.50M |
| June 30, 2015 | -24.39M |
| March 31, 2015 | -24.75M |
| December 31, 2014 | -25.36M |
| September 30, 2014 | -10.62M |
| June 30, 2014 | -3.877M |
| March 31, 2014 | -3.956M |
| December 31, 2013 | -3.318M |
| September 30, 2013 | -3.732M |
| June 30, 2013 | -1.62M |
| March 31, 2013 | -1.547M |
| December 31, 2012 | -1.112M |
| September 30, 2012 | -0.537M |
| June 30, 2012 | -0.542M |
| March 31, 2012 | -0.225M |
| December 31, 2011 | -0.343M |
| September 30, 2011 | -24.84M |
| June 30, 2011 | -25.27M |
| March 31, 2011 | -25.49M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-14.82M
Minimum
Jun 2020
7.143M
Maximum
Sep 2022
-2.248M
Average
-0.453M
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
| Fonar Corp | -3.114M |
| XWELL Inc | 5.65M |
| ProPhase Labs Inc | -1.369M |
| Applied DNA Sciences Inc | -1.141M |
| Veracyte Inc | 15.11M |